Announcements Trials
Browse Landscape

Phase

Phase NA 13Phase 3 2Phase EARLY_PHASE1 1Phase 1/2 1

Status

Completed 80Recruiting 56Terminated 39Unknown 34Active not recruiting 19Not yet recruiting 6Withdrawn 4Suspended 4Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 6CNS 4Breast 3Thoracic 2Other solid neoplasm 2Genitourinary 2Tumor-Agnostic 1Sarcoma 1Plasma cell 1Other hematologic neoplasm 1NET 1Lymphoid 1Head & Neck 1Gynecologic 1Endocrine 1Dermatologic 1

Conditions

Neoplasms 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Enrolling by invitation × Tumor-Agnostic × Clear all
NCT05741242 2026-01-15

A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors

Jaime Leandro Foundation for Therapeutic Cancer Vaccines

Phase 1/2 Enrolling by invitation
136 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡